Calamos Advisors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
Calamos Advisors's VCYT Position: Q1 2022 in Review
Calamos Advisors sold out of Veracyte (VCYT) in Q1 2022, closing a stake of 21,475 shares — an estimated $884K sold.
Calamos Advisors first reported a position in VCYT in Q2 2019 and held it in 7 quarters. The position peaked at $5.64M in Q2 2019. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.
- Calamos Advisors reported no remaining Veracyte position as of Q1 2022 after selling out during the quarter.
- Calamos Advisors sold 21,475 Veracyte shares in Q1 2022, an estimated $884K.
- Calamos Advisors first reported a position in Veracyte in Q2 2019 and held it in 7 quarters.
- Calamos Advisors's Veracyte position peaked at $5.64M in Q2 2019.
- 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.
Based on Calamos Advisors's 13F filing for Q1 2022, filed 3 May 2022.